Ethyl 1-methyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

Columna HPLC NUCLEODUR® 100-3 C18 ec 3 µm, 150 mm, 4,6 mm, 1 Pieza(s)

(R)-TETRAHYDRO-3H-PYRROLO[1,2-C][1,2,3]OXATHIAZOLE 1,1-DIOXIDE, 95.0%, 250mg

Ethyl 5-(4-fluorophenyl)-5-oxovalerate, 97.0%, 10g

4-methyl-2-hexanone, 95.0%, 250mg

2,4-BIS(METHYLTHIO)QUINAZOLINE, 95.0%, 250mg

4-Aminotetrahydrofuran-3-ol, 95.0%, 5g

(2,5-Dimethoxyphenyl)methanol, 95.0%, 25g

N-Methyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 1g

5-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carboxylic acid, 95.0%, 10g

2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2S,3R)-, 97%, 5mg

N-(4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)acetamide hydrochloride, 95.0%, 250mg

Fosfato de hidrógeno disódico 12 H2O, mínimo 98,5 %, Ph.Eur., 1 kg, envase de plástico.